Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending
On December 15, 2025, Barclays analyst Luke Sergott raised the price target for TXG from $17 to $22 while maintaining an Overweight rating, reflecting confidence in the company’s positioning in life...






